458 filings
4
Mark L. Jacobson
1 Apr 24
Axsome Therapeutics / Mark L. Jacobson ownership change
6:46pm
144
Mark L. Jacobson
1 Apr 24
Notice of proposed sale of securities
6:14pm
8-K
AXSM
Axsome Therapeutics Inc
1 Apr 24
Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder
8:27am
8-K
AXSM
Axsome Therapeutics Inc
25 Mar 24
Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients
9:06am
8-K
AXSM
Axsome Therapeutics Inc
25 Mar 24
Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy
9:02am
8-K
m9sjqy94
19 Mar 24
Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder
7:06am
4
jhpp2lzc2bapb
15 Mar 24
Axsome Therapeutics / ROGER JEFFS ownership change
8:05pm
144
b3jw euajfing0vq
15 Mar 24
Notice of proposed sale of securities
7:09pm
144
ehaec khmxy
14 Mar 24
Notice of proposed sale of securities
4:20pm
4
gt5ohblx hluwal7z9bf
29 Feb 24
Axsome Therapeutics / ROGER JEFFS ownership change
6:34pm
4
jgrp0c1o spf
29 Feb 24
Axsome Therapeutics / Mark E Saad ownership change
6:34pm
4
czcc7
29 Feb 24
Axsome Therapeutics / Mark L. Jacobson ownership change
6:34pm
4
wjmzmqyesotru1uc
29 Feb 24
Axsome Therapeutics / Nick Pizzie ownership change
6:25pm
4
p1ms3
29 Feb 24
Axsome Therapeutics / HERRIOT TABUTEAU ownership change
6:20pm
4
5dkw23 4jtp4pvq
29 Feb 24
Axsome Therapeutics / Susan Mahony ownership change
6:18pm
4
iv572h71
29 Feb 24
Axsome Therapeutics / Hunter R. Murdock ownership change
5:39pm
8-K
p0krl9
20 Feb 24
Corporate Presentation February 2024
4:30pm
8-K
3ct87z
20 Feb 24
Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
7:05am
SC 13G/A
fndu q82iq8uhadb
14 Feb 24
Axsome Therapeutics / Fairmount Funds Management ownership change
3:46pm